Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Clinical trial NCT02559934 · COMPLETED
Trial details
- NCT number
- NCT02559934
- Sponsor
- G&E Herbal Biotechnology Co., LTD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2019-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.